Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimsat MV 2mg/500mg/0.3mg Tablet

Prescription Icon
Prescription Required

Marketer

Saturn Formulations Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Glimsat MV 2mg/500mg/0.3mg Tablet

Diabetace Plus 2mg/500mg/0.3mg tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes. It effectively manages blood glucose levels. Diabetace Plus should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with well-controlled blood sugar, as abrupt cessation can lead to elevated glucose, increasing the risk of kidney complications, vision loss, neuropathy, and limb loss. This medication is part of a comprehensive treatment plan encompassing a balanced diet, regular exercise, and weight management as advised by your doctor; lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most prevalent adverse effect. Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and be prepared to treat them promptly with a fast-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption elevates hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalgia, edema, blurred vision, fractures, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Patients with a history of cardiovascular disease should inform their physician prior to commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Uses of Glimsat MV 2mg/500mg/0.3mg Tablet

Managing Type 2 Diabetes

Major Benefits of Glimsat MV 2mg/500mg/0.3mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Glimsat MV 2mg/500mg/0.3mg Tablets should be administered on an empty stomach.

Common Side effects of Glimsat MV 2mg/500mg/0.3mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glimsat MV 2mg/500mg/0.3mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Glimsat MV 2mg/500mg/0.3mg Tablet should be administered on an empty stomach.

How Glimsat MV 2mg/500mg/0.3mg Tablet works:

Each Glimsat MV tablet (2mg/500mg/0.3mg) combines three distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Glimsat MV 2mg/500mg/0.3mg tablets is dangerous.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimsat MV 2mg/500mg/0.3mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glimsat MV 2mg/500mg/0.3mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyUNSAFE

The use of Glimsat MV 2mg/500mg/0.3mg tablets carries a high risk for individuals with kidney impairment and is best avoided. Patients with severe kidney disease should definitely not use this medication. Medical advice is essential.

LiverLiverCAUTION

Patients with liver impairment should use Glimsat MV 2mg/500mg/0.3mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiating treatment with a low dose is typical; however, its use is contraindicated in cases of severe liver disease.

What if you forget to take Glimsat MV 2mg/500mg/0.3mg Tablet :

Should you forget to take your Glimsat MV 2mg/500mg/0.3mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.

Facts to Know About Glimsat MV 2mg/500mg/0.3mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimsat MV 2mg/500mg/0.3mg Tablet

Glimsat MV 2mg/500mg/0.3mg tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release, metformin reduces liver glucose production and enhances insulin sensitivity, and voglibose, an alpha-glucosidase inhibitor, lowers post-meal glucose levels. This medication is not suitable for type 1 DM.
Glimsat MV 2mg/500mg/0.3mg Tablets may cause common side effects including low blood sugar (hypoglycemia), nausea, diarrhea, altered taste perception, gas, stomach pain, headache, skin rash, and respiratory infections.
Glimsat MV 2mg/500mg/0.3mg Tablets are contraindicated in patients allergic to any component or excipient. They should also be avoided in those with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Glimsat MV 2mg/500mg/0.3mg tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glimsat MV 2mg/500mg/0.3mg Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimsat MV 2mg/500mg/0.3m...
107
MRP 130
17% off